These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 10505563)
1. Calcium and strontium metabolic studies in patients on CAPD. Apostolidis N; Paradellis T; Karydas A; Manouras A; Katirtzoglou N; Mayopoulou-Symvoulidou D Perit Dial Int; 1998; 18(4):410-4. PubMed ID: 10505563 [TBL] [Abstract][Full Text] [Related]
2. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group. Weinreich T; Ritz E; Passlick-Deetjen J Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540 [TBL] [Abstract][Full Text] [Related]
4. Endothelin-1 in continuous ambulatory peritoneal dialysis and hemodialysis patients: a preliminary study. Lightfoot BO; Caruana RJ Perit Dial Int; 1993; 13(1):55-8. PubMed ID: 8443279 [TBL] [Abstract][Full Text] [Related]
5. Short-term effects of low-calcium dialysis solutions on calcium mass transfer, ionized calcium, and parathyroid hormone in CAPD patients. Pagliari B; Baretta A; De Cristofaro V; Samà F; Cantaluppi A; Martis L; Imbasciati E Perit Dial Int; 1991; 11(4):326-9. PubMed ID: 1751598 [TBL] [Abstract][Full Text] [Related]
6. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis. Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702 [TBL] [Abstract][Full Text] [Related]
7. Age-related changes in strontium to calcium ratios in rat tissues. Sugihira N; Kobayashi E; Suzuki KT Biol Trace Elem Res; 1990 Apr; 25(1):79-88. PubMed ID: 1696115 [TBL] [Abstract][Full Text] [Related]
8. Spectrum of renal osteodystrophy in children on continuous ambulatory peritoneal dialysis. Yalçinkaya F; Ince E; Tümer N; Ensari A; Ozkaya N Pediatr Int; 2000 Feb; 42(1):53-7. PubMed ID: 10703235 [TBL] [Abstract][Full Text] [Related]
9. [Effect of strontium on bone metabolism in hemodialysis patients]. Gerstenfeld S; Hinojosa L; Serrano Arias M; Menéndez Rodríguez P; Fernández Martín JL; Marchante JM; García Alonso JI; Sanz-Medel A; Cannata Andía JB Nefrologia; 2003; 23 Suppl 2():52-6. PubMed ID: 12778855 [TBL] [Abstract][Full Text] [Related]
10. Pyridinium crosslinks in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Ibrahim S; Mojiminiyi S; Barron JL Nephrol Dial Transplant; 1995 Dec; 10(12):2290-4. PubMed ID: 8808228 [TBL] [Abstract][Full Text] [Related]
11. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group. Weinreich T; Passlick-Deetjen J; Ritz E Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324 [TBL] [Abstract][Full Text] [Related]
12. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Joffe P; Olsen F; Heaf JG; Gammelgaard B; Pödenphant J Clin Nephrol; 1989 Sep; 32(3):133-8. PubMed ID: 2791364 [TBL] [Abstract][Full Text] [Related]
13. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients. Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653 [TBL] [Abstract][Full Text] [Related]
14. Stable strontium absorption as a measure of intestinal calcium absorption: comparison with the double-radiotracer calcium absorption test. Blumsohn A; Morris B; Eastell R Clin Sci (Lond); 1994 Sep; 87(3):363-8. PubMed ID: 7955914 [TBL] [Abstract][Full Text] [Related]
15. Calcium kinetic studies in patients on CAPD: improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover. Kurz P; Tsobanelis T; Brunkhorst R; Roth P; Werner E; Schoeppe W; Vlachojannis J Perit Dial Int; 1997; 17(1):59-65. PubMed ID: 9068024 [TBL] [Abstract][Full Text] [Related]
16. Effect of CAPD and hemodialysis on parathyroid function. Malberti F; Corradi B; Imbasciati E Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912 [TBL] [Abstract][Full Text] [Related]
17. [Dynamic changes in calcium and phosphate plasma concentrations in the patients on peritoneal dialysis]. Jovanović N; Lausević M; Stojimirović B Vojnosanit Pregl; 2006 Jan; 63(1):27-30. PubMed ID: 16471245 [TBL] [Abstract][Full Text] [Related]
18. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options]. Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261 [TBL] [Abstract][Full Text] [Related]
19. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients. Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934 [TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]